Earnings Alerts

China Pacific Insurance (Group) Co. (601601) Earnings: YTD Life Premium Income Hits 228.8B Yuan with Positive Market Ratings

By December 11, 2024 No Comments
  • China Pacific reported year-to-date life premium income of 228.8 billion yuan.
  • The company’s year-to-date property and casualty insurance premium income is 187 billion yuan.
  • Analyst recommendations for China Pacific include 21 buy ratings, 4 hold ratings, and 0 sell ratings.

A look at China Pacific Insurance (Group) Co., Smart Scores

FactorScoreMagnitude
Value4
Dividend5
Growth4
Resilience3
Momentum2
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Pacific Insurance (Group) Company, Ltd. is displaying strong fundamentals as per Smartkarma Smart Scores. With high scores in Dividend and Value, the company shows promise in providing steady returns to investors. Additionally, its Growth score indicates potential for expansion, while its Resilience score reflects its ability to withstand market challenges. However, the company lags in Momentum, suggesting a slower pace in stock price movement.

Looking ahead, China Pacific Insurance (Group) Co. holds a positive long-term outlook due to its solid performance in key metrics. Investors may find the company attractive for its strong dividend yield and underlying value. While the lower Momentum score may indicate a slower uptrend, the overall outlook remains favorable for those seeking a stable and potentially growing investment in the insurance sector.

Summary: China Pacific Insurance (Group) Company, Ltd. is an integrated insurance services provider offering life and property insurance products through its subsidiaries.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars